Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System
CRISPR-Cas systems are immune systems that protect bacteria and archaea against their viruses, bacteriophages. Immunity is achieved through the acquisition of short DNA fragments from the viral invader’s genome.
Guardado en:
Autores principales: | Ville Hoikkala, Janne Ravantti, César Díez-Villaseñor, Marja Tiirola, Rachel A. Conrad, Mark J. McBride, Sylvain Moineau, Lotta-Riina Sundberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40618c52dbb54ff1897caf4ad4630ba1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term genomic coevolution of host-parasite interaction in the natural environment
por: Elina Laanto, et al.
Publicado: (2017) -
Characterization of a Type II-A CRISPR-Cas System in <italic toggle="yes">Streptococcus mutans</italic>
por: Cas Mosterd, et al.
Publicado: (2020) -
Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins
por: Alexander P. Hynes, et al.
Publicado: (2018) -
CRISPR–Cas9-targeted fragmentation and selective sequencing enable massively parallel microsatellite analysis
por: GiWon Shin, et al.
Publicado: (2017) -
High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
por: Kevin Neil, et al.
Publicado: (2021)